Literature DB >> 10960638

Depomedroxyprogesterone-induced hypoestrogenism and changes in vaginal flora and epithelium.

L Miller1, D L Patton, A Meier, S S Thwin, T M Hooton, D A Eschenbach.   

Abstract

OBJECTIVE: To identify the effects of depomedroxyprogesterone acetate (DMPA) on vaginal microbial flora and epithelium.
METHODS: Women who desired DMPA for contraception were evaluated before and at 3 and 6 months after initiation of 150-mg DMPA injections every 3 months. At each visit, we assessed genital symptoms, vaginal signs, vaginal microflora, and histopathology by vaginal biopsies.
RESULTS: Among 38 women observed for 6 months, there was significant reduction in mean serum estradiol level (99.9 +/- 9.3 pg/mL to 26.6 +/- 1.6 pg/mL, P <.001). The number of subjects with any Lactobacillus did not change, but the number with hydrogen peroxide (H(2)O(2))-positive Lactobacillus decreased from 20% before to 12% after 6 months of DMPA (P =.005). The log concentration in colony-forming units per milliliter of vaginal fluid of H(2)O(2)-positive Lactobacillus decreased in a linear manner from 4. 0 +/- 0.6 at baseline to 2.5 +/- 0.6 after 6 months of DMPA use (P =. 006). The mean number of cell layers in the epithelium was reduced slightly from 28.1 +/- 0.7 to 25.9 +/- 0.9 (P =.05), epithelial thickness decreased from 1.02 +/- 0.04 mm to 0.89 +/- 0.05 mm (P =. 005), and the glycogen-positive thickness decreased from 0.81 +/- 0. 04 mm at baseline to 0.66 +/- 0.05 after 6 months of DMPA use (P =. 005).
CONCLUSION: Depomedroxyprogesterone acetate produced a systemic hypoestrogenic state associated with decreased H(2)O(2)-positive Lactobacillus colonization and slight thinning of the glycogen vaginal epithelial layer. Such changes possibly compromise the vaginal barrier to infection.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10960638     DOI: 10.1016/s0029-7844(00)00906-6

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  70 in total

Review 1.  Modulation of autoimmune rheumatic diseases by oestrogen and progesterone.

Authors:  Grant C Hughes; Divaker Choubey
Journal:  Nat Rev Rheumatol       Date:  2014-08-26       Impact factor: 20.543

2.  Long-term effect of depot medroxyprogesterone acetate on vaginal microbiota, epithelial thickness and HIV target cells.

Authors:  Caroline M Mitchell; Leslie McLemore; Katharine Westerberg; Rena Astronomo; Kimberly Smythe; Carolyn Gardella; Matthias Mack; Amalia Magaret; Dorothy Patton; Kathy Agnew; M Juliana McElrath; Florian Hladik; David Eschenbach
Journal:  J Infect Dis       Date:  2014-03-20       Impact factor: 5.226

Review 3.  Hormonal Contraception and HIV-1 Acquisition: Biological Mechanisms.

Authors:  Janet P Hapgood; Charu Kaushic; Zdenek Hel
Journal:  Endocr Rev       Date:  2018-02-01       Impact factor: 19.871

Review 4.  Innate and adaptive anti-HIV immune responses in the female reproductive tract.

Authors:  Marta Rodriguez-Garcia; Mickey V Patel; Charles R Wira
Journal:  J Reprod Immunol       Date:  2013-03       Impact factor: 4.054

5.  The effect of menopause on the innate antiviral activity of cervicovaginal lavage.

Authors:  Catherine A Chappell; Charles E Isaacs; Weimin Xu; Leslie A Meyn; Kevin Uranker; Charlene S Dezzutti; Bernard J Moncla; Sharon L Hillier
Journal:  Am J Obstet Gynecol       Date:  2015-03-25       Impact factor: 8.661

6.  Progesterone-based intrauterine device use is associated with a thinner apical layer of the human ectocervical epithelium and a lower ZO-1 mRNA expression.

Authors:  Annelie Tjernlund; Ann M Carias; Sonia Andersson; Susanna Gustafsson-Sanchez; Maria Röhl; Pernilla Petersson; Andrea Introini; Thomas J Hope; Kristina Broliden
Journal:  Biol Reprod       Date:  2015-01-14       Impact factor: 4.285

7.  Rapid clearance of herpes simplex virus type 2 by CD8+ T cells requires high level expression of effector T cell functions.

Authors:  Michelle H Nelson; Melanie D Bird; Chin-Fun Chu; Alison J Johnson; Brian M Friedrich; Windy R Allman; Gregg N Milligan
Journal:  J Reprod Immunol       Date:  2011-03-27       Impact factor: 4.054

Review 8.  Sex steroid hormones, hormonal contraception, and the immunobiology of human immunodeficiency virus-1 infection.

Authors:  Zdenek Hel; Elizabeth Stringer; Jiri Mestecky
Journal:  Endocr Rev       Date:  2009-11-10       Impact factor: 19.871

Review 9.  Research gaps in defining the biological link between HIV risk and hormonal contraception.

Authors:  Kerry Murphy; Susan C Irvin; Betsy C Herold
Journal:  Am J Reprod Immunol       Date:  2014-02-19       Impact factor: 3.886

Review 10.  Early life microbial exposures and allergy risks: opportunities for prevention.

Authors:  Harald Renz; Chrysanthi Skevaki
Journal:  Nat Rev Immunol       Date:  2020-09-11       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.